Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patientsAdding drug to standard chemotherapy provides no survival benefit for older lung cancer patients Public release date: 17-Apr-2012 [ | E-mail | Share ] Contact: Anne Doerr anne_doerr@dfci.harvard.edu 617-632-5665 Dana-... more | |||||